Quotient Clinical, the Translational Pharmaceutics® company, has expanded its clinical spray drying capability through the acquisition of a Niro Mobile Minor™ Spray Dryer.

Quotient has a proven track record of developing spray-dried dispersions to overcome  drug compound solubility issues, and the addition of a larger scale spray dryer will allow the production of a range of batch sizes, from milligrams up to two kilograms.
 
Sited at Quotient’s new GMP facility at MediCity in Nottingham, UK – scheduled to open later in 2016 – this expansion is a direct response to customer requests for ongoing product development support, including toxicology and later stage clinical studies.
 
Nikki Whitfield, VP of Pharmaceutical Sciences, commented: “Poor solubility is increasingly prevalent in drug pipelines across the industry. We have established a broad suite of formulation approaches within our Translational Pharmaceutics platform to address these complex solubility and bioavailability challenges, and this latest investment will allow us to efficiently scale up the production of optimised formulations to support our clients’ downstream clinical development programs.” 
 
For further information, please contact:
 
Robin Bodicoat
Marketing Director
Quotient Clinical
Tel: +44 (0)115 931 5102
robin.bodicoat@quotientclinical.com

 
About Quotient Clinical
Quotient Clinical offers unique services – based on its Translational Pharmaceutics® platform – that integrate formulation development, real-time drug product manufacturing and clinical testing, significantly reducing the time and cost of bringing a drug to market. For more than 20 years, Quotient Clinical has brought innovation to drug product development programs for pharmaceutical and biotechnology customers worldwide. The company is based in purpose-built, fully integrated facilities in the UK, where formulation development, real-time GMP manufacturing and early clinical trials are performed in the same facility. It employs over 320 staff, offering a full range of support services, from study set-up right through to data analysis and reporting. Quotient Clinical was recently acquired by specialist healthcare investor GHO Capital who will support the future development of the company.

Find out more